Healthier World with Quest Diagnostics: Laboratory Assessment in PCOS Diagnosis and Management
Episode Released: June 5, 2024
Introduction to PCOS
In the latest episode of Healthier World with Quest Diagnostics, host Sarah Walsh delves into the complexities of diagnosing and managing Polycystic Ovary Syndrome (PCOS) alongside Dr. Sanjay Dixit, a board-certified endocrinologist and Quest Diagnostics medical director. The discussion underscores the prevalence of PCOS, challenges in its diagnosis, and the critical role of laboratory assessments in effective management.
Key Points:
- Prevalence of PCOS: PCOS affects an estimated 5 to 6 million women in the U.S., making it the most common endocrine disorder among reproductive-aged females.
- Diagnostic Challenges: Up to 75% of individuals with PCOS remain undiagnosed, often experiencing delays in diagnosis after consulting multiple healthcare professionals.
Sarah Walsh [00:05]: "Polycystic Ovary Syndrome is a common and complex hormonal disorder that impacts millions of women across the globe."
Dr. Sanjay Dixit [02:05]: "PCOS is a diagnosis of exclusion. Many other disease states can cause similar signs and symptoms that present in PCOS."
Understanding PCOS: Definitions and Symptoms
Dr. Dixit provides a comprehensive overview of PCOS, defining it as a disorder characterized by androgen excess and ovarian dysfunction. He emphasizes that PCOS is not merely about polycystic ovaries, highlighting the multifaceted nature of the syndrome.
Key Points:
- Androgen Excess: Symptoms include hirsutism (excessive hair growth), thinning hair, androgenic alopecia, and facial acne.
- Ovulatory Dysfunction: Manifested as irregular menstrual cycles (oligomenorrhea or amenorrhea) and infertility.
- Polycystic Ovarian Morphology: While commonly associated with PCOS, it is not a mandatory criterion for diagnosis.
Dr. Sanjay Dixit [03:10]: "In terms of androgen excess, one would see in a patient things like hirsutism, thinning hair, androgenic alopecia... Ovulatory dysfunction refers to menstrual abnormalities."
Diagnostic Criteria for PCOS
The conversation shifts to the diagnostic criteria for PCOS, with a focus on the widely accepted Rotterdam Criteria. Dr. Dixit outlines the necessary conditions for diagnosis and underscores the importance of excluding other potential disorders.
Rotterdam Criteria:
- Irregular Menses: Oligomenorrhea or amenorrhea.
- Hyperandrogenism: Clinical signs (e.g., hirsutism) or biochemical evidence (elevated androgen levels).
- Polycystic Ovarian Morphology: Detected via ultrasound.
A diagnosis of PCOS requires at least two of these three criteria.
Dr. Sanjay Dixit [04:21]: "The Rotterdam Criteria are the most widely accepted criteria for the diagnosis of PCOS... two of the following three characteristics need to be present."
Laboratory Assessments for Hyperandrogenism
A critical aspect of PCOS diagnosis is assessing hyperandrogenism through laboratory tests. Dr. Dixit discusses the appropriate methodologies and the importance of accurate testing.
Key Points:
- Total and Free Testosterone: Essential for evaluating biochemical hyperandrogenism.
- Total Testosterone: Should be measured using liquid chromatography tandem mass spectrometry (LC-MS/MS).
- Free Testosterone: Best assessed through equilibrium dialysis or reliable calculation methods.
- Additional Androgens: If initial tests are inconclusive, androstenedione and DHEA sulfate may be measured, though they offer lower specificity.
Dr. Sanjay Dixit [06:14]: "The total testosterone should be of a liquid chromatography tandem mass spec assay. Immunoassay used in women is not appropriate."
Sarah Walsh [07:42]: "For assessing total testosterone in female, the preferred and guideline recommended methodology is liquid chromatography mass spectrometry..."
Excluding Other Conditions
Since PCOS is a diagnosis of exclusion, it's imperative to rule out other conditions that mimic its symptoms. Dr. Dixit identifies the common disorders that clinicians must exclude during the diagnostic process.
Conditions to Exclude:
- Pregnancy: Verified using an HCG level.
- Hyperprolactinemia: Assessed through serum prolactin levels.
- Thyroid Disorders: Evaluated with TSH and possibly free T4 tests.
- Non-Classic Congenital Adrenal Hyperplasia: Diagnosed via an 8 AM 17-hydroxyprogesterone level.
Dr. Sanjay Dixit [09:18]: "The first and possibly the most important condition to exclude is pregnancy... Second, hyperprolactinemia... Third, hypo and hyperthyroidism... Fourth, non-classic congenital adrenal hyperplasia."
Role of Anti-Mullerian Hormone (AMH) in PCOS
The discussion explores the utility of Anti-Mullerian Hormone (AMH) in diagnosing PCOS, highlighting its advantages and limitations.
Key Points:
- AMH as a Diagnostic Tool: Elevated AMH levels are common in PCOS and can define polycystic ovarian morphology.
- Methodological Considerations: Variability in assays, inverse relationship with BMI, suppression by oral contraceptives, and its inappropriateness in adolescents.
- Guideline Recommendations: AMH or transvaginal ultrasound can be used, but not both simultaneously.
Dr. Sanjay Dixit [11:30]: "Serum AMH could be used for defining polycystic ovarian morphology in adults... AMH is not necessary for PCOS diagnosis."
Special Considerations for Different Populations
Dr. Dixit addresses the unique aspects of diagnosing PCOS in adolescents and postmenopausal women.
Adolescents:
- Challenges: Irregular menstrual cycles are common and normal during adolescence, complicating the diagnosis.
- Guidelines: Increased risk assessment and reassessment after reproductive maturity (8 years post-menarche).
- AMH Use: Not recommended in this population.
Postmenopausal Women:
- Persistence of Symptoms: Hyperandrogenism can continue post-menopause.
- Retrospective Diagnosis: Based on history of symptoms during reproductive years.
- Cardiometabolic Risk: Emphasis on evaluating cardiovascular health post-menopause.
Dr. Sanjay Dixit [13:06]: "If the adolescent has some PCOS features but doesn't meet the diagnostic criteria, the provider could consider the patient at increased risk... After a female has gone through menopause... important to try to evaluate a patient's cardiometabolic risk."
Cardiometabolic Risks Associated with PCOS
PCOS extends beyond reproductive health, significantly impacting cardiometabolic health. Dr. Dixit highlights the increased risks and necessary evaluations for patients diagnosed with PCOS.
Cardiometabolic Concerns:
- Type 2 Diabetes: Women with PCOS are four times more likely to develop diabetes by age 40, with 50% diagnosed by that age.
- Other Risks: Cardiovascular disease, hypertension, metabolic syndrome, sleep apnea, and fatty liver disease.
Recommended Evaluations:
- Lipid Panel: At diagnosis and periodically thereafter.
- Glycemic Status: Preferably via an oral glucose tolerance test, but alternatives include fasting glucose, hemoglobin A1C, or insulin resistance panels.
Dr. Sanjay Dixit [15:07]: "Women with PCOS are at increased risk of a whole slew of cardiometabolic conditions... 50% of all women with PCOS will develop type 2 diabetes by the age of 40."
Tools and Resources for Clinicians
Quest Diagnostics supports healthcare providers with diagnostic algorithms and educational resources to streamline PCOS diagnosis and management.
Available Resources:
- Diagnostic Algorithms: Aligning medical society guidelines with comprehensive endocrine test menus.
- Clinical Focus on PCOS: In-depth information accessible via podcast descriptions.
- Educational Webinars: Recorded sessions featuring PCOS experts like Dr. Andrea Dunaef.
Sarah Walsh [16:58]: "Like I said, appreciate an algorithm for our listeners today. Note that the algorithm is linked in the podcast description."
Final Takeaways
As the episode concludes, both Sarah Walsh and Dr. Dixit emphasize the importance of timely diagnosis and comprehensive management of PCOS to mitigate long-term health risks.
Key Takeaways:
- Regular Menstrual Cycles: Irregular menses in reproductive-aged females warrant further investigation.
- Multidisciplinary Approach: PCOS management requires collaboration across specialties, especially primary care and endocrinology.
- Cardiometabolic Vigilance: The alarming statistic that 50% of women with PCOS may develop type 2 diabetes by 40 underscores the necessity for vigilant monitoring.
Dr. Sanjay Dixit [18:00]: "Remember that staggering statistic that 50% of females with PCOS will develop type 2 diabetes by the age of 40."
Conclusion
This episode of Healthier World with Quest Diagnostics provides a thorough exploration of PCOS, from its prevalence and diagnostic criteria to the essential laboratory assessments and long-term health implications. By equipping clinicians with the necessary tools and knowledge, Quest Diagnostics aims to enhance the accuracy and efficiency of PCOS diagnosis and management, ultimately fostering a healthier world.
For more detailed information and resources discussed in this episode, listeners are encouraged to visit the Quest Diagnostics Clinical Education Center and explore the additional links provided in the podcast description.
Thank you for tuning into Healthier World with Quest Diagnostics. Stay informed and proactive in creating a healthier world, one life at a time.